26.49 USD
+0.34 (+1.3%)
At close: Jan 30, 2026
26.49 USD
0 (0%)
After Hours: 1/30/2026, 8:00:00 PM
We assign a fundamental rating of 6 out of 10 to AMPH. AMPH was compared to 191 industry peers in the Pharmaceuticals industry. While AMPH belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. AMPH may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make AMPH suitable for value investing!
1. Profitability
1.1 Basic Checks
- In the past year AMPH was profitable.
- AMPH had a positive operating cash flow in the past year.
- Each year in the past 5 years AMPH has been profitable.
- AMPH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- AMPH's Return On Assets of 6.70% is amongst the best of the industry. AMPH outperforms 87.96% of its industry peers.
- AMPH has a Return On Equity of 14.37%. This is amongst the best in the industry. AMPH outperforms 87.96% of its industry peers.
- AMPH has a better Return On Invested Capital (8.51%) than 86.91% of its industry peers.
- AMPH had an Average Return On Invested Capital over the past 3 years of 12.92%. This is in line with the industry average of 12.82%.
- The last Return On Invested Capital (8.51%) for AMPH is well below the 3 year average (12.92%), which needs to be investigated, but indicates that AMPH had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.7% | ||
| ROE | 14.37% | ||
| ROIC | 8.51% |
ROA(3y)10.51%
ROA(5y)8.2%
ROE(3y)20.19%
ROE(5y)14.97%
ROIC(3y)12.92%
ROIC(5y)10.14%
1.3 Margins
- Looking at the Profit Margin, with a value of 15.43%, AMPH belongs to the top of the industry, outperforming 87.43% of the companies in the same industry.
- AMPH's Profit Margin has improved in the last couple of years.
- The Operating Margin of AMPH (20.73%) is better than 88.48% of its industry peers.
- AMPH's Operating Margin has improved in the last couple of years.
- AMPH's Gross Margin of 49.36% is fine compared to the rest of the industry. AMPH outperforms 64.40% of its industry peers.
- AMPH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.73% | ||
| PM (TTM) | 15.43% | ||
| GM | 49.36% |
OM growth 3Y20.68%
OM growth 5YN/A
PM growth 3Y15.39%
PM growth 5Y7.52%
GM growth 3Y3.84%
GM growth 5Y4.54%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMPH is still creating some value.
- Compared to 1 year ago, AMPH has less shares outstanding
- AMPH has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for AMPH has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.40 indicates that AMPH is not a great score, but indicates only limited risk for bankruptcy at the moment.
- The Altman-Z score of AMPH (2.40) is better than 64.40% of its industry peers.
- The Debt to FCF ratio of AMPH is 5.49, which is a neutral value as it means it would take AMPH, 5.49 years of fcf income to pay off all of its debts.
- AMPH has a Debt to FCF ratio of 5.49. This is amongst the best in the industry. AMPH outperforms 82.20% of its industry peers.
- AMPH has a Debt/Equity ratio of 0.78. This is a neutral value indicating AMPH is somewhat dependend on debt financing.
- AMPH has a Debt to Equity ratio of 0.78. This is in the lower half of the industry: AMPH underperforms 70.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 5.49 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.94
WACC9.03%
2.3 Liquidity
- A Current Ratio of 3.12 indicates that AMPH has no problem at all paying its short term obligations.
- AMPH has a Current ratio (3.12) which is comparable to the rest of the industry.
- AMPH has a Quick Ratio of 2.21. This indicates that AMPH is financially healthy and has no problem in meeting its short term obligations.
- AMPH's Quick ratio of 2.21 is in line compared to the rest of the industry. AMPH outperforms 46.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.12 | ||
| Quick Ratio | 2.21 |
3. Growth
3.1 Past
- AMPH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.95%.
- Measured over the past years, AMPH shows a very strong growth in Earnings Per Share. The EPS has been growing by 61.62% on average per year.
- The Revenue has decreased by -0.03% in the past year.
- AMPH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.82% yearly.
EPS 1Y (TTM)-9.95%
EPS 3Y41.58%
EPS 5Y61.62%
EPS Q2Q%-3.12%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y18.69%
Revenue growth 5Y17.82%
Sales Q2Q%0.33%
3.2 Future
- Based on estimates for the next years, AMPH will show a small growth in Earnings Per Share. The EPS will grow by 0.14% on average per year.
- The Revenue is expected to grow by 4.14% on average over the next years.
EPS Next Y-8.73%
EPS Next 2Y-1.9%
EPS Next 3Y0.87%
EPS Next 5Y0.14%
Revenue Next Year-0.8%
Revenue Next 2Y1.99%
Revenue Next 3Y2.7%
Revenue Next 5Y4.14%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- AMPH is valuated cheaply with a Price/Earnings ratio of 7.70.
- Based on the Price/Earnings ratio, AMPH is valued cheaper than 93.19% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.32. AMPH is valued rather cheaply when compared to this.
- With a Price/Forward Earnings ratio of 7.13, the valuation of AMPH can be described as very cheap.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of AMPH indicates a rather cheap valuation: AMPH is cheaper than 92.67% of the companies listed in the same industry.
- AMPH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.7 | ||
| Fwd PE | 7.13 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMPH indicates a rather cheap valuation: AMPH is cheaper than 91.62% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, AMPH is valued cheaply inside the industry as 90.05% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.97 | ||
| EV/EBITDA | 7.35 |
4.3 Compensation for Growth
- The excellent profitability rating of AMPH may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-1.9%
EPS Next 3Y0.87%
5. Dividend
5.1 Amount
- AMPH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMPHASTAR PHARMACEUTICALS IN / AMPH FAQ
What is the fundamental rating for AMPH stock?
ChartMill assigns a fundamental rating of 6 / 10 to AMPH.
What is the valuation status of AMPHASTAR PHARMACEUTICALS IN (AMPH) stock?
ChartMill assigns a valuation rating of 8 / 10 to AMPHASTAR PHARMACEUTICALS IN (AMPH). This can be considered as Undervalued.
Can you provide the profitability details for AMPHASTAR PHARMACEUTICALS IN?
AMPHASTAR PHARMACEUTICALS IN (AMPH) has a profitability rating of 9 / 10.
What is the valuation of AMPHASTAR PHARMACEUTICALS IN based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMPHASTAR PHARMACEUTICALS IN (AMPH) is 7.7 and the Price/Book (PB) ratio is 1.57.